All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Kalamazoo, Mich.-based Stryker Corp. just scored a win after the FDA gave the green light for marketing two Trevo clot retrieval devices as first-line treatments to reduce disability in patients experiencing ischemic stroke. It is the first therapy to receive the front-line designation in this indication in 20 years, the company said.